Genetic Variation in the Platelet Endothelial Aggregation Receptor 1 Gene Results in Endothelial Dysfunction

Area of Science:

• Cardiovascular Biology
• Molecular Genetics
• Vascular Medicine

Background:

• Platelet Endothelial Aggregation Receptor 1 (PEAR1) is a membrane protein implicated in vascular and thrombotic processes.
• While studied in platelets, PEAR1 is highly expressed in the endothelium, suggesting a key role in endothelial function.

Purpose of the Study:

• To evaluate PEAR1's role in endothelial function using flow-mediated dilation.
• To computationally define PEAR1's impact on cardiovascular disease via microarray meta-analysis.
• To investigate the association between PEAR1 genetic variation and endothelial function.

Main Methods:

• Flow-mediated dilation assessment in 641 participants.
• Meta-analysis of 75,000 microarrays to identify PEAR1-associated genes and phenotypes.
• Ex vivo endothelial cell migration assays to validate genetic associations.

Main Results:

• A significant association was found between PEAR1 genetic variation (rs12041331) and flow-mediated dilation (P = 0.02).
• PEAR1 expression correlated with genes (ANG2, ACVRL1, ENG) and phenotypes (angiogenesis, endothelial cell migration) vital for endothelial function.
• The rs12041331 variant was significantly linked to endothelial cell migration (P = 0.04).

Conclusions:

• Genetic variation in PEAR1 is a significant determinant of endothelial function.
• PEAR1 influences cardiovascular disease pathways through its role in endothelial processes.
• This study highlights PEAR1 as a potential target for cardiovascular disease interventions.